New Elite Feature: Screen & Chart at the same time

5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment

By Ekta Bagri | July 02, 2025, 9:28 AM

Immunocore Holdings plc ADR

Kiniksa Pharmaceuticals International Plc

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Exelixis, Inc. (EXEL): Free Stock Analysis Report

Alkermes plc (ALKS): Free Stock Analysis Report

Verona Pharma PLC American Depositary Share (VRNA): Free Stock Analysis Report

Kiniksa Pharmaceuticals International, plc (KNSA): Free Stock Analysis Report

Immunocore Holdings PLC Sponsored ADR (IMCR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Immunocore Holdings plc ADR

Kiniksa Pharmaceuticals International Plc

Latest News

May-19	Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer EXEL Business Wire
May-12	Alkermes Announces Positive Topline Results From REVITALYZ Phase 3 Study Evaluating LUMRYZ (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia ALKS +7.95% Business Wire
May-07	Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May EXEL -5.11% Business Wire
May-06	Immunocore reports first quarter financial results and provides a business update IMCR +6.55% GlobeNewswire
May-05	Exelixis, Inc. Q1 2026 Earnings Call Summary EXEL Moby
May-05	Alkermes plc Q1 2026 Earnings Call Summary ALKS +6.09% Moby
May-05	Exelixis: Q1 Earnings Snapshot EXEL +9.64% EXEL Associated Press
May-05	Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update EXEL +9.64% EXEL Business Wire
May-05	Alkermes: Q1 Earnings Snapshot ALKS +6.09% Associated Press
May-05	Alkermes plc Reports First Quarter 2026 Financial Results ALKS +6.09% Business Wire
Apr-29	Kiniksa Pharmaceuticals International PLC (KNSA) Q1 2026 Earnings Call Highlights: Robust ... KNSA GuruFocus.com
Apr-28	Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution KNSA +23.48% GlobeNewswire
Apr-23	Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 KNSA GlobeNewswire
Apr-21	Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026 EXEL +5.23% Business Wire
Apr-21	Alkermes to Report First Quarter Financial Results on May 5, 2026 ALKS Business Wire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)